July 27, 2023
Via: Contract PharmaAyala Pharmaceuticals, Inc., a clinical-stage oncology company, and BioSight Ltd., a pharmaceutical company developing therapeutics for hematological malignancies and disorders, entered into a definitive merger agreement pursuant to which Ayala will combine with Biosight in an all-stock transaction. The combined […]
July 19, 2024
July 11, 2024
July 11, 2024